Black v. Littlejohn

325 S.E.2d 469, 312 N.C. 626, 1985 N.C. LEXIS 1500
CourtSupreme Court of North Carolina
DecidedJanuary 30, 1985
Docket196A84
StatusPublished
Cited by152 cases

This text of 325 S.E.2d 469 (Black v. Littlejohn) is published on Counsel Stack Legal Research, covering Supreme Court of North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Black v. Littlejohn, 325 S.E.2d 469, 312 N.C. 626, 1985 N.C. LEXIS 1500 (N.C. 1985).

Opinion

FRYE, Justice.

On 1 October 1978, defendant, a licensed physician specializing in obstetrics and gynecology, performed surgery on plaintiff. The surgical procedures performed included a total abdominal hysterectomy, a bilateral salpingo oophorectomy, appendectomy and lysis of adhesions. Defendant prescribed and performed the surgery for plaintiff to alleviate and resolve a certain condition diagnosed by defendant as endometriosis. Plaintiff, in her af *627 fidavit, stated that defendant told her “he had done everything he could to avoid a hysterectomy and that nothing else would work.” On 17 August 1981, plaintiff, who was at that time employed as a medical secretary, changed units on her job. Thereafter, she became aware that a drug called Danocrine was being used to treat endometriosis. In September or October 1981, plaintiff was advised by a doctor and resident where she worked that her hysterectomy “might have been unnecessary.” These incidents aroused in plaintiff “some suspicions that Danocrine should have been tried in my case.”

Afterwards, plaintiff was again treated for endometriosis by a second doctor, Dr. Jonathan Weston. During July 1982, Dr. Weston prescribed Danocrine to treat plaintiffs condition. Plaintiff called the Food and Drug Administration and learned that the drug had been approved for the treatment of endometriosis on 21 June 1976 and had been available for use by physicians as early as September 1976, a date more than two years before defendant had performed surgery to treat plaintiffs endometriosis. Plaintiff in her affidavit stated that “it was only when I began being treated with Danocrine for my present endometriosis that it was completely apparent to me that my hysterectomy was unnecessary.”

On 16 August 1982, plaintiff commenced a medical malpractice action against defendant, alleging lack of informed consent to the surgery performed by defendant. Defendant, in his answer, denied any negligence on his part. He also included in his answer a motion to dismiss, pursuant to Rule 12(b)(6), asserting that the action was barred by the three-year statute of limitations contained in G.S. l-15(c). The motion to dismiss was allowed by order entered 26 October 1982, dismissing the complaint. Plaintiff timely appealed to the Court of Appeals, and that court affirmed the trial court’s dismissal of plaintiffs action.

I.

The issue on this appeal is whether plaintiffs discovery of defendant’s failure to inform her of the availability of a drug as a less drastic alternative to the hysterectomy performed by defendant on plaintiff more than two years earlier qualifies as discovery of a non-apparent “injury” that comes within the one-year discovery provision of G.S. l-15(c). This Court concludes that it does.

*628 The heart of the controversy in this case centers around an interpretation of G.S. l-15(c), the statute of limitations applicable to professional malpractice actions. That statute states:

Except where otherwise provided by statute, a cause of action for malpractice arising out of the performance of or failure to perform professional services shall be deemed to accrue at the time of the occurrence of the last act of the defendant giving rise to the cause of action: Provided that whenever there is bodily injury to the person, economic or monetary loss, or a defect in or damage to property which originates under circumstances making the injury, loss, defect or damage not readily apparent to the claimant at the time of its origin, and the injury, loss, defect or damage is discovered or should reasonably be discovered by the claimant two or more years after the occurrence of the last act of the defendant giving rise to the cause of action, suit must be commenced within one year from the date discovery is made: Provided nothing herein shall be construed to reduce the statute of limitation in any such case below three years. Provided further, that in no event shall an action be commenced more than four years from the last act of the defendant giving rise to the cause of action: Provided further, that where damages are sought by reason of a foreign object, which has no therapeutic or diagnostic purpose or effect, having been left in the body, a person seeking damages for malpractice may commence an action therefor within one year after discovery thereof as hereinabove provided, but in no event may the action be commenced more than 10 years from the last act of the defendant giving rise to the cause of action.

It is plaintiffs contention that she suffered from an injury that was not readily apparent at the time of its origin, that is, at the time of the operation on 1 October 1978; and that her discovery of her alleged injury at some point after 17 August 1981, a date more than two years after the surgery, brings her within the second provision of G.S. l-15(c). If applicable, this portion of the statute would allow plaintiff one year from the date of her discovery of the “injury, loss, defect, or damage” to bring an action for malpractice. Furthermore, plaintiff did commence her action on 16 August 1982, a date within one year after her alleged *629 discovery, thus satisfying this particular requirement of the statute.

This one-year-from-discovery exception contained within the second provision of G.S. l-15(c) is subject to a four-year absolute or outer time limit within which plaintiff must bring an action for malpractice. This outer time limit begins with the last act of the defendant giving rise to the cause of action. Since plaintiff commenced her malpractice action on 16 August 1982, or within one year after she allegedly discovered her injury and within four years from the last act of defendant when he performed surgery on 1 October 1978, she contends that the trial court improperly granted defendant’s motion to dismiss based upon the three-year statute of limitations contained in G.S. l-15(c).

The Court of Appeals held that plaintiffs cause of action accrued on 1 October 1978, the date on which defendant performed the surgery on plaintiff, and that her injury was apparent, thus bringing her within the three-year limitation period contained in the first provision of G.S. l-15(c). That court disagreed with plaintiffs contention that she did not discover her injury until more than two years after the surgery was performed and that she should be allowed to take advantage of the discovery provision for non-apparent injuries within G.S. l-15(c). The primary reason for the Court of Appeals’ refusal to allow plaintiff the additional time afforded by this second provision rests upon that court’s interpretation of what the legislature meant by plaintiff s discovery of an “injury, . . . not readily apparent to the claimant at the time of its origin, . . .” Without citation of authority, the Court of Appeals reasoned that the term “injury” should be interpreted as follows:

The clear purpose of the exception in G.S. 1-15(c) allowing for a four-year limitation period in certain cases is to provide for latent injuries where the physical damage to a prospective plaintiff is not readily apparent, and not for those cases in which the injury is obvious but the alleged negligence of the doctor is not. We do not believe our legislature intended to equate discovery of injury with the discovery of negligence.

67 N.C. App. at 213, 312 S.E. 2d at 911.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Christopher J. Rogers
M.D. North Carolina, 2025
Bald Head Island Ltd., LLC v. Vill. of Bald Head Island
Court of Appeals of North Carolina, 2025
United Therapeutics Corp. v. Roscigno
2025 NCBC 25 (North Carolina Business Court, 2025)
McKinney v. Goins
Supreme Court of North Carolina, 2025
Ellis v. Sanofi US Services Inc.
W.D. North Carolina, 2024
Devito v. Biomet, Inc.
E.D. North Carolina, 2024
Taylor v. Bank of America, N.A.
Supreme Court of North Carolina, 2024
Warren v. Snowshoe LTC Grp.
Court of Appeals of North Carolina, 2024
Wynn v. Frederick
Supreme Court of North Carolina, 2023
Autry v. Bill Clark Homes
Court of Appeals of North Carolina, 2022
Futures Grp., Inc. v. Brosnan
2022 NCBC 79 (North Carolina Business Court, 2022)
McNew v. Fletcher Hosp., Inc.
2022 NCBC 53 (North Carolina Business Court, 2022)
McFee v. Presley
2022 NCBC 33 (North Carolina Business Court, 2022)
Oliver v. Brown & Morrison, Ltd.
2022 NCBC 13 (North Carolina Business Court, 2022)
Bryant v. Wake Forest Univ. Baptist Med. Ctr.
Court of Appeals of North Carolina, 2022
BOND v. JOHNSON & JOHNSON
D. New Jersey, 2021
Chisum v. Campagna
Supreme Court of North Carolina, 2021

Cite This Page — Counsel Stack

Bluebook (online)
325 S.E.2d 469, 312 N.C. 626, 1985 N.C. LEXIS 1500, Counsel Stack Legal Research, https://law.counselstack.com/opinion/black-v-littlejohn-nc-1985.